GROUPAMA ASSET MANAGMENT

Position in INCY — Incyte Corp

CIK 1055969 PARIS, I0

Position in INCY

as of Mar 31, 2026 · filed May 22, 2026 Compact

Position Value

$6,254,368

-$1,060,439 QoQ

Shares Held

66,451

-10.3% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 82.50289687137891.ToString("F0")% Shared 0.ToString("F0")% None 17.497103128621088.ToString("F0")%

Healthcare · as of Mar 31, 2026

GROUPAMA ASSET MANAGMENT holds $249,620,066 across 10 Biotechnology names. INCY ranks #7 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	165,897	$74,079,646
2	IONS	Ionis Pharmaceuticals Inc	824,540	$61,914,708
3	REGN	Regeneron Pharmaceuticals, Inc.	71,102	$54,936,249
4	MDGL	Madrigal Pharmaceuticals, Inc.	35,238	$18,446,035
5	BNTX	BioNTech SE	185,036	$16,445,999
6	ALNY	Alnylam Pharmaceuticals, Inc.	36,767	$12,165,097
7	INCY	Incyte Corp This page	66,451	$6,254,368
8	DNLI	Denali Therapeutics Inc.	207,130	$3,976,896

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,254,368	66,451	-10.3%	Shares	Sole	2026-05-22
2025-12-31	$7,314,807	74,059	+1.3%	Shares	Sole	2026-02-27
2025-09-30	$6,197,490	73,075	+1.4%	Shares	Sole	2025-12-01
2025-06-30	$4,909,192	72,088	+5.9%	Shares	Sole	2025-08-13
2025-03-31	$4,120,124	68,045	+12.4%	Shares	Sole	2025-05-14
2024-12-31	$4,182,810	60,559	+1.6%	Shares	Sole	2025-02-12
2024-09-30	$3,939,361	59,597	+11.4%	Shares	Sole	2024-11-15
2024-06-30	$3,242,685	53,492	+5.9%	Shares	Sole	2024-08-14
2024-03-31	$2,878,010	50,518	-26.4%	Shares	Sole	2024-05-14
2023-12-31	$4,309,780	68,638	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.